| 摘要 |
<p>The present invention relates to an immunomodulator (e.g., immunoenhancer and immunosupressant) capable of oral intake which has a novel suppressive function on macrophages (hereinafter sometimes abbreviated as "M PHI ") or monocytes and which is especially intended for treatment, improvement and prevention of human immunological diseases such as hepatic cirrhosis, hepatitis, diabetes, gastrointestinal inflammatory diseases such as inflammatory bowel diseases (ulcerative colitis, Crohn disease, etc.), auto-immunological diseases and allergic diseases such as hypersensitive interstitial pneumonia, pulmonary fibrosis, chronic rheumatoid arthritis, asthma and cutaneous atopy, and cancers, and to a drug, a food (including a food for medical care, a health food or a special sanitary food), a nutrient and an infusion containing the same.</p> |
